ProShare Advisors’s FibroGen FGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-495
Closed -$11K 2090
2024
Q2
$11K Sell
495
-169
-25% -$3.77K ﹤0.01% 1831
2024
Q1
$39K Buy
664
+53
+9% +$3.11K ﹤0.01% 1934
2023
Q4
$13.5K Sell
611
-118
-16% -$2.62K ﹤0.01% 1936
2023
Q3
$15.7K Buy
729
+3
+0.4% +$65 ﹤0.01% 1797
2023
Q2
$49K Buy
726
+53
+8% +$3.58K ﹤0.01% 1774
2023
Q1
$314K Sell
673
-88
-12% -$41K ﹤0.01% 1188
2022
Q4
$305K Buy
761
+60
+9% +$24K ﹤0.01% 1228
2022
Q3
$229K Buy
701
+17
+2% +$5.55K ﹤0.01% 1315
2022
Q2
$180K Sell
684
-347
-34% -$91.3K ﹤0.01% 1502
2022
Q1
$310K Sell
1,031
-244
-19% -$73.4K ﹤0.01% 1609
2021
Q4
$449K Buy
1,275
+42
+3% +$14.8K ﹤0.01% 1534
2021
Q3
$315K Sell
1,233
-445
-27% -$114K ﹤0.01% 1514
2021
Q2
$1.12M Buy
1,678
+211
+14% +$140K ﹤0.01% 976
2021
Q1
$1.27M Buy
1,467
+99
+7% +$85.9K ﹤0.01% 863
2020
Q4
$1.27M Buy
1,368
+315
+30% +$292K ﹤0.01% 787
2020
Q3
$1.08M Sell
1,053
-20
-2% -$20.6K 0.01% 702
2020
Q2
$1.09M Buy
1,073
+352
+49% +$357K 0.01% 681
2020
Q1
$627K Sell
721
-535
-43% -$465K ﹤0.01% 690
2019
Q4
$1.35M Sell
1,256
-112
-8% -$120K 0.01% 715
2019
Q3
$1.27M Sell
1,368
-35
-2% -$32.4K 0.01% 691
2019
Q2
$1.59M Sell
1,403
-213
-13% -$241K 0.01% 640
2019
Q1
$2.2M Buy
1,616
+55
+4% +$74.7K 0.01% 580
2018
Q4
$1.81M Sell
1,561
-286
-15% -$331K 0.01% 590
2018
Q3
$2.81M Buy
1,847
+49
+3% +$74.4K 0.02% 539
2018
Q2
$2.81M Sell
1,798
-87
-5% -$136K 0.02% 558
2018
Q1
$2.18M Sell
1,885
-296
-14% -$342K 0.01% 602
2017
Q4
$2.59M Buy
2,181
+167
+8% +$198K 0.02% 552
2017
Q3
$2.71M Buy
2,014
+368
+22% +$495K 0.02% 499
2017
Q2
$1.33M Buy
1,646
+56
+4% +$45.2K 0.01% 653
2017
Q1
$980K Sell
1,590
-416
-21% -$256K 0.01% 752
2016
Q4
$1.07M Buy
2,006
+182
+10% +$97.4K 0.01% 743
2016
Q3
$944K Sell
1,824
-292
-14% -$151K 0.01% 698
2016
Q2
$868K Buy
2,116
+44
+2% +$18K 0.01% 765
2016
Q1
$1.1M Sell
2,072
-180
-8% -$95.8K 0.02% 673
2015
Q4
$1.72M Buy
+2,252
New +$1.72M 0.02% 556